Scanning and Transmission Electron Microscopy Reveals Graphene Oxide in CoV-19 Vaccines
Dr Robert O Young
Naturopathic Practitioner and Biochemist, Research Scientist at the pH Miracle, Valley Center, California
*Corresponding Author: Dr Robert O Young, Naturopathic Practitioner and Biochemist, Research Scientist at the pH Miracle, Valley Center, California.
May 17, 2022; Published: July 26, 2022
Currently there are four major pharmaceutical companies who manufacture a SARS-CoV-2 now called SARS-CoV-19 vaccine. These manufactures and their vaccine are Pfizer--BioNTech mRNA Vaccine, the Moderna-Lonza mRNA-1273 Vaccine, the Serum Institute Oxford Astrazeneca Vaccine and the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson and Johnson, a recombinant, replication-incompetent adenovirus type 26 expressing the SARS-CoV-2 spike protein . The intended purpose of these vaccines are to provide immunity from the so-called infectious novel coronavirus or SARS-CoV-2 virus now called the SARS-CoV-19. These four pharmaceutical companies have not provided complete FDA disclosure on their vaccine box, insert fact sheet or label for many of the major and/or minor ingredients contained within these so-called vaccines. The purpose of this research article is to identify those specific major and minor ingredients contained in the Pfizer Vaccine, the Moderna Vaccine, the Astrazeneca Vaccine and the Janssen Vaccine using various scientific anatomical, physiological and functional testing for each SARS-COV-2-19 vaccine. As a human right, governed under World Law by the Nuremberg Code of 1947, the vaccine specific ingredient information is critical, required and necessary to know so that any human from any country in the World can make an informed decision whether or not to consent to the SAR-CoV-2-19 inoculation . We have conducted the scientific testing on each vaccine and have identified several ingredients or adjuvants that have not been disclosed which are contained in these four SARS-CoV-2-19 vaccines. Currently, these vaccines are being administered to millions of humans around the World under an Emergency Use Authorization (EUA) issued by each country without full disclosure of all ingredients and in some cases mandated by governments or employers in violation of individual human rights under the Nuremberg Code of 1947 .
Keywords: SARS; CoV-19; Vaccine; Bioweapon; 5G; Graphene; Graphene Oxide; Graphene Hydroxide; Parasite; Trypanosoma; PEG; Polyethylene Glycol; Nano Dots; rGO; GO; mRNA; Pfizer; Moderna; Astrazenica; Janssen Pharmaceutical; Electron Microscopy; Fluorescence Microscopy; Brightfield Microscopy; Darkfield Microscopy; pHase Contrast Microscopy; UV Absorbance; Fluorescence Spectroscopy; Transmission Microscopy; Energy Dispersive Spectroscopy; X-ray Diffractometer; Nuclear Magnetic Resonance; Vaccine Ingredients
- Zhao J., et al. “COVID-19: Coronavirus Vaccine Development Updates”. Frontiers in Immunology 11 (2020): 602256.
- Ghooi RB. “The Nuremberg Code-A critique”. Perspectives in Clinical Research 2 (2011): 72-76.
- Rizk JG., et al. “Expanded access programs, compassionate drug use, and emergency use authorizations during the COVID-19 pandemic”. Drug Discover Today2 (2021): 593-603.
- , et al. “Identification of graphene oxide and its structural features in solvents by optical microscopy”. RSC Advances 9 (2019): 18559-18564.
- Xu L., et al. “Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity”. Nanoscale 6 (2016): 3785-3795.
- Xu L., et al. “Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity”. Nanoscale6 (2016): 3785-3795.
- Ou L., et al. “Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms”. Particle and Fibre Toxicology 57 (2016).
- Young RO and Migalko G. “What Causes Oxygen Deprivation of the Blood (DIC) and Then Lungs (SARS-CoV 2 and 19)?”. Integral Molecular 1 (2020): 001-007.
- Young RO. “Pathological Blood Coagulation and the Mycotoxic Oxidative Stress Test (MOST)”. International Journal of Vaccines and Vaccination 6 (2016): 00048.
- Ou L., et al. “Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms”. Particle and Fibre Toxicology57 (2016).
- Atlas of Human Parasitology, 4th Edition, Lawrence Ash and Thomas Orithel 174 to 178.
- "Graphene Ribbons Show Promise as Semiconductors". Chemical and Engineering News, Bethany Halford 86.4 (2008).
- Muestra RD. La Quinta Columna Report, June 28, 2021; Graphene Oxide Detection in Aqueous Suspension; Delgado Martin, Campra Madrid (2021).
- Bilek G., et al. “Liposomal nanocontainers as models for viral infection: monitoring viral genomic RNA transfer through lipid membranes”. Journal of Virology16 (2011): 8368-8375.
- Renata H., et al. “Characterization of graphene nanosheets obtained a modified Hummer’s method”. RevistaMateria01 (2018).
- , et al. “Seeing graphene-based sheets”. Materials Today 13.3 (2010): 28-38.
- Bano I., et al. “Exploring the fluorescence properties of reduced graphene oxide with tunable device performance”. Diamond and Related Materials 94 (2019): 59-64.
- Biroju Ravi., et al. “New advances in 2D electrochemistry—Catalysis and Sensing” (2018).
- Lai Q., et al. “Ultraviolet-visible spectroscopy of graphene oxides”. AIP Advances (2012).
- Mano SS., et al. “Effect of Polyethylene Glycol Modification of TiO2 Nanoparticles on Cytotoxicity and Gene Expressions in Human Cell Lines”. International Journal of Molecular Sciences 13 (2012): 3703-3717.
- Young RO. "The Effects of ElectroMagnetic Frequencies (EMF) on the Blood and Biological Terrain".
- Lieber, Charles 66 patents which are being used as scaffolds and wires and nanosensors and semiconductors in all vaccines as described here.
- Ana V., et al. “Drug delivery systems based on nanoparticles and related nanostructures”. European Journal of Pharmaceutical Sciences 151 (2020): 105412.
- "Graphene Ribbons Show Promise as Semiconductors". Chemical and Engineering News, Bethany Halford 86.4 (2008). https://cen.acs.org/articles/86/i4/Graphene-Ribbons.html
- Ou L., et al. “Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms”. Particle and Fibre Toxicology 13 (2016): 57.
- Wei Jiang., et al. “Study on magnetic properties of a nano-graphene bilayer”. Carbon 95 (2015): 190-198.
- Maingredy RodriguesSouza., et al. “Can nanomaterials induce reproductive toxicity in male mammals?” A historical and critical review”. Science of The Total Environment 769 (2021).
- Nujiang Tang., et al. “Magnetic properties of graphene". Editor (s): Wenqing Liu, Yongbing Xu, In Materials Today, Spintronic 2D Materials, Elsevier (2020): 137-161.
- Gatti AM., et al. “Nano biointeraction of particulate matter in the blood circulation”. Frontiers 30 (2016): 3.
- Ivask Angela., et al. “Toxicity of 11 Metal Oxide Nanoparticles to Three Mammalian Cell Types <i>In V.itro</i>”. Current Topics in Medicinal Chemistry18 (2015): 1914-1929.
- Elisa Moschini., et al. “The modality of cell-particle interactions drives the toxicity of nanosized CuO and TiO2 in human alveolar epithelial cells”. Toxicology Letters 222 (2013): 102-116.
- Nikazar S., et al. “Revisiting the cytotoxicity of quantum dots: an in-depth overview”. Biophysics Review 12 (2020): 703-718.
- Ritesh Banerjee., et al. “Cadmium selenide (CdSe) quantum dots cause genotoxicity and oxidative stress in Allium cepa plants”. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 865 (2021): 503338.
- Wanjun Cao., et al. “Recent progress of graphene oxide as a potential vaccine carrier and adjuvant”. Acta Biomaterialia 112 (2020): 14-28.
- Zhang L., et al. “SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome”. bioRxiv Preprint 13 (2020): 2020.12.12.422516.
- Nano coronavirus recombinant vaccine taking graphene oxide as carrier - Patent.
- Concise Encyclopedia of Composite Materials, ed. Anthony Kelly, MIT Press (1989).
- L Harivardhan Reddy., et al. “Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications”. Chemical Reviews11 (2012): 5818-5878.
- US Dpt of health and human services (1996) Report Update: Vaccine Side Effects, Adverse Reactions, Contraindications, and Precautions. CDC 45 (RR-12): 1-35.
- Extraction RNA Kit.